This association likely reflects a ‘cardio-hepatic’ interaction, where elevated AST serves as a surrogate marker for hepatic congestion or hypoperfusion secondary to underlying heart failure or haemodynamic instability—conditions known to exacerbate thromboembolic risk. Here, GOT1 is linked to heart failure.